{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:46:25Z","timestamp":1785840385865,"version":"3.56.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Major bleeding, and intracranial bleeding specifically, are severe complications related to the use of anticoagulation. To what extent the risk for major bleeding is elevated among frail older people is not well known because they are underrepresented in the randomized clinical trials (RCTs). This study investigates the risk for major bleeding (MB) and intra cranial haemorrhage (ICH) in frail older people who fall.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All patients 65 years and older visiting the Fall and Syncope Clinic, between November 2011 and January 2020, and underwent a MRI of the brain were eligible. Frailty was assessed with a Frailty Index, based on the accumulation of deficits model. Cerebral small vessel disease was described and evaluated as proposed in the position paper of Wardlaw and colleagues in 2013.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>479 patients were included in this analysis. Mean follow-up was 7 years per patient (ranging from 1 month to 8 years and 5 months). 368 patients (77%) were frail. A total of 81 patients used oral anticoagulation (OAC). 17 extracranial MB of which 3 were traumatic and 14 gastrointestinal, and 16 ICH occurred. There was a total of 603.4 treatment years with OAC, and 8 MBs occurred among patients on OAC (bleeding rate 1.32 per 100 treatment years), of which 2 ICHs (bleeding rate 0.33 per 100 treatment years). The risk for extracranial MB was increased by the use of antiplatelet agents (APA) (adjusted OR 6.9, CI 95% 1.2\u201338.3), and by the use of OAC (adjusted OR 9.8, CI 95% 1.7\u201356.1). The risk for ICH was only heightened by white matter hyperintensities (WMH) (adjusted OR 3.8, CI 95% 1.0-13.4). The use of APA (adjusted OR 0.9, CI 95% 0.3\u20133.3) or OAC (adjusted OR 0.6, CI 95% 0.1\u20133.3) did not elevate the risk for ICH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In contrast to common belief, frail patients on OAC with repeated falls show a comparable bleeding rate as in the large RCTs, and the use of OAC did not increase the risk for ICH. However, the number of MBs was low, and of ICHs very low, despite extensive follow-up in this registry.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12877-023-04120-9","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:03:06Z","timestamp":1689004986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Frail patients who fall and their risk on major bleeding and intracranial haemorrhage. Outcomes from the Fall and Syncope Registry"],"prefix":"10.1186","volume":"23","author":[{"given":"LAR","family":"Zwart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Germans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Vogels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MEW","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RWMM","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"3","key":"4120_CR1","first-page":"146","volume":"56A","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontology: Med Sci. 2001;56A(3):146\u201356.","journal-title":"J Gerontology: Med Sci"},{"issue":"7","key":"4120_CR2","first-page":"722","volume":"62A","author":"K Rockwood","year":"2007","unstructured":"Rockwood K, Mitnitski A. Frailty in Relation to the Accumulation of deficits. J Gerontology: Med Sci. 2007;62A(7):722\u20137.","journal-title":"J Gerontology: Med Sci"},{"issue":"26","key":"4120_CR3","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/eurheartj\/ehu197","volume":"35","author":"M Singh","year":"2014","unstructured":"Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. Eur Heart J. 2014;35(26):1726\u201331.","journal-title":"Eur Heart J"},{"key":"4120_CR4","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic surgery (EACTS). Eur Heart J. 2020."},{"issue":"3","key":"4120_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.geriatr.1903071","volume":"3","author":"L Zwart","year":"2019","unstructured":"Zwart L, Germans T, Simsek S, Ruiter J, Jansen R. Atrial Fibrillation, Anticoagulation, and major bleeding episodes in geriatric patients at the risk of falling. OBM Geriatr. 2019;3(3):1.","journal-title":"OBM Geriatr"},{"issue":"3","key":"4120_CR6","first-page":"149","volume":"17","author":"LA Zwart","year":"2020","unstructured":"Zwart LA, Jansen RW, Ruiter JH, Germans T, Simsek S, Hemels ME. Opportunistic screening for atrial fibrillation with a single lead device in geriatric patients. J Geriatr Cardiol. 2020;17(3):149\u201354.","journal-title":"J Geriatr Cardiol"},{"key":"4120_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurger.2015.05.007","volume":"6","author":"JFH Wold","year":"2015","unstructured":"Wold JFH, Ruiter JH, Cornel JH, Vogels RLC, Jansen RWWM. A multidisciplinary care pathway for the evaluation of falls and syncope in geriatric paties. Eur Geriatr Med. 2015;6:7.","journal-title":"Eur Geriatr Med"},{"key":"4120_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non surgical patients. J Thromb Haemost. 2005;3:692\u20134.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"4120_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338.","journal-title":"Lancet Neurol"},{"issue":"35","key":"4120_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR Signal Abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR. 1987;149(35):351\u20136.","journal-title":"AJR"},{"issue":"10","key":"4120_CR11","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4120_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24.","journal-title":"BMC Geriatr"},{"issue":"7","key":"4120_CR13","first-page":"738","volume":"62A","author":"A Rockwood","year":"2007","unstructured":"Rockwood A et, Mitnitski. A comparison of two approaches to measuring frailty in elderly people. J Gerontology: Med Sci. 2007;62A(7):738\u201343.","journal-title":"J Gerontology: Med Sci"},{"issue":"4","key":"4120_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","volume":"167","author":"EC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien EC, Holmes DN, Ansell JE, Allen LA, Hylek E, Kowey PR, et al. Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Am Heart J. 2014;167(4):601\u20139e1.","journal-title":"Am Heart J"},{"key":"4120_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","volume":"211","author":"M Madhavan","year":"2019","unstructured":"Madhavan M, Holmes DN, Piccini JP, Ansell JE, Fonarow GC, Hylek EM, et al. Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation. Am Heart J. 2019;211:77\u201389.","journal-title":"Am Heart J"},{"key":"4120_CR16","unstructured":"NHG, NHG-Standaard Atriumfibrilleren. HenW. 2017:95."},{"issue":"8","key":"4120_CR17","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/01.STR.0000080678.09344.8D","volume":"34","author":"MJ Ariesen","year":"2003","unstructured":"Ariesen MJ, Claus SP, Rinkel GJ, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003;34(8):2060\u20135.","journal-title":"Stroke"},{"issue":"6","key":"4120_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","volume":"17","author":"D Wilson","year":"2018","unstructured":"Wilson D, Ambler G, Shakeshaft C, Brown MM, Charidimou A, Al-Shahi Salman R, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol. 2018;17(6):539\u201347.","journal-title":"Lancet Neurol"},{"issue":"8","key":"4120_CR19","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.04.027","volume":"28","author":"MK Badi","year":"2019","unstructured":"Badi MK, Vilanilam GK, Gupta V, Barrett KM, Lesser ER, Cochuyt JJ, et al. Pharmacotherapy for patients with Atrial Fibrillation and Cerebral Microbleeds. J Stroke Cerebrovasc Dis. 2019;28(8):2159\u201367.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"4120_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1378\/chest.10-3270","volume":"Jul","author":"DA Lane","year":"2011","unstructured":"Lane DA, Kamphuisen PW, Minimi P, B\u00fcller HR, Lip GY. Bleeding risk in patients with atrial fibrillation: the AMADEUS study. Chest. 2011;Jul(1):146\u201355.","journal-title":"Chest"},{"issue":"12","key":"4120_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom JW, Oldgren J, Parekh A, et al. Dabigatran versus Warfarin in patients with Atrial Fibrillation. N Engl J Med. 2009;361(12):13.","journal-title":"N Engl J Med"},{"issue":"11","key":"4120_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):12.","journal-title":"N Engl J Med"},{"issue":"22","key":"4120_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):12.","journal-title":"N Engl J Med"},{"issue":"10","key":"4120_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):9.","journal-title":"N Engl J Med"},{"issue":"4","key":"4120_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief Screening Tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):965\u2013699.","journal-title":"J Am Geriatr Soc"},{"key":"4120_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000352051","volume":"36","author":"L Koski","year":"2013","unstructured":"Koski L. Validity and applications of the Montreal Cognitive Assessment for the Assessment of Vasculair Cognitive Impairment. Cerebrovasc Dis. 2013;36:6\u201318.","journal-title":"Cerebrovasc Dis"},{"key":"4120_CR27","doi-asserted-by":"crossref","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roque IFM, Ciapponi A, Sanchez-Perez E, Giannakou A et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015(3):CD010783.","DOI":"10.1002\/14651858.CD010783.pub2"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-023-04120-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-023-04120-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:05:39Z","timestamp":1689005139000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-023-04120-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1186\/s12877-023-04120-9","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"17 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Only data gathered during routine care was used for this analysis, and patients were not exposed to any study intervention, nor were decisions in clinical care influenced by the gathering of data. All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the ethical board of the North West Clinics. Informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript contains no patient identifying data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}